Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells

Oncogene

Volumn 18, Issue 17, 1999, Pages 2777-2782

  Haber, M ^a   Bordow, S B ^a   Gilbert, J ^a   Madafiglio, J ^a   Kavallaris, M ^a   Marshall, G M ^a   Mechetner, E B ^b   Fruehauf, J P ^b   Tee, L ^b   Cohn, S L ^c   Salwen, H ^c   Schmidt, M L ^d   Norris, M D ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b Oncotech Inc   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antisense; Cytotoxicity; MRP gene; MYCN oncogene; Neuroblastoma; Transfection

Indexed keywords

ANTIMONY TARTRATE; ARSENATE SODIUM; CISPLATIN; COMPLEMENTARY RNA; CYTOTOXIC AGENT; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEUROBLASTOMA; ONCOGENES; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0033614367     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202859     Document Type: Article

References (22)

1. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD. (1994). Cancer Res., 54, 5036-5040.
2. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, Schneider S, Wasson J, White P, Seeger RC, Look T and Castleberry R. (1992). Cancer, 70, 1685-1694.
3. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG. (1992). Science, 258, 1650-1654.
4. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG. (1994). Cancer Res., 54, 5902-5910.
5. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Sheper RJ and Zaman GJ. (1994). Cancer Res., 54, 4557-4563.
6. Grandori C and Eisenman RN. (1997). Trends Biochem. Sci., 22, 177-181.
7. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP and Deeley RG. (1994). Cancer Res., 54, 357-361.
8. Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L and Stewart BW. (1989). Cancer Res., 49, 5281-5287.
9. Lee J-S, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G and Bates SE. (1997). J. Cell. Biochem., 65, 513-526.
10. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M. (1996). N. Engl. J. Med., 334, 231-238.
11. Norris MD, Bordow SB, Haber PS, Marshall GM, Kavallaris M, Madafiglio J, Cohn SL, Salwen H, Schmidt ML, Hipfner DR, Cole SPC, Deeley RG and Haber M. (1997). Eur. J. Cancer, 33, 1911-1916.
12. Norris MD, Madafiglio J, Gilbert J, Marshall GM and Haber M. (1998). Eur. J. Cancer, in press.
13. Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A and Calabretta B. (1994). Cancer Res., 54, 2251-2255.
14. Ross RA, Spengler BA and Biedler JL. (1983). J. Natl. Cancer Inst., 71, 741-749.
15. Schmidt ML, Salwen HR, Manohar CF, Ikegaki N and Cohn SL. (1994). Cell Growth Differ., 5, 171-178.
16. Schneider E, Horton JK, Yang C-H, Nakagawa M and Cowan KH. (1994). Cancer Res., 54, 152-158.
17. Schwab M, Varmus HE and Bishop JM. (1985). Nature, 316, 160-162.
18. Spengler BA, Ross RA and Biedler JL. (1986). Cancer Treat Rep., 70, 959-965.
19. Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Brodeur GM and Seeger RC. (1996). J. Clin. Oncol., 14, 2417-2426.
20. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG and Bishop JM. (1997). EMBO J., 16, 2985-2995.
21. Wenzel A and Schwab M. (1995). Eur. J. Cancer, 31A, 516-519.
22. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P. (1994). Proc. Natl. Acad. Sci. USA, 91, 8822-8826.